Skip to content

Most ‘HAART-associated’ symptoms may not be attributable to drug therapy, study claims

Report of rare atazanavir-related liver side-effect published

Tenofovir and efavirenz show promise as a two drug maintenance regimen

Once-daily regimens improve adherence and treatment satisfaction

Could monotherapy with Kaletra become an option for HIV treatment?

Stopping NNRTIs in drug-resistant patients does not alter viral loads or CD4 cell counts

Atazanavir significantly reduces lipids 12 weeks after switching from nelfinavir

Switching to abacavir restores some fat loss over 2 years, but other body disturbances unchanged

Prodrug of tenofovir works well in the presence of some NRTI resistance